Varian Medical Systems, Inc.  

(Public, NYSE:VAR)   Watch this stock  
Find more results for VAR
-1.48 (-1.57%)
Jan 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 92.35 - 94.62
52 week 76.73 - 95.70
Open 93.35
Vol / Avg. 1.42M/715,243.00
Mkt cap 9.27B
P/E 24.08
Div/yield     -
EPS 3.84
Shares 99.98M
Beta 0.88
Inst. own 91%
Apr 29, 2015
Q2 2015 Varian Medical Systems Inc Earnings Release - 4:00PM EDT - Add to calendar
Feb 12, 2015
Varian Medical Systems Inc Annual Shareholders Meeting - 7:30PM EST - Add to calendar
Jan 28, 2015
Q1 2015 Varian Medical Systems Inc Earnings Call
Jan 28, 2015
Q1 2015 Varian Medical Systems Inc Earnings Release
Jan 13, 2015
Varian Medical Systems Inc at JPMorgan Healthcare Conference
Nov 24, 2014
Varian Medical Systems Inc at Brean Capital's Life Sciences Summit Conference
Nov 5, 2014
Varian Medical Systems Inc Year End Review in New York City
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '15) 2014
Net profit margin 12.64% 13.24%
Operating margin 17.55% 18.73%
EBITD margin - 21.15%
Return on average assets 11.08% 11.83%
Return on average equity 23.15% 24.24%
Employees 6,800 -
CDP Score - 84 C


3100 Hansen Way
PALO ALTO, CA 94304-1030
United States - Map
+1-650-4245834 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. The Company's Oncology Systems business segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiotherapy, including IMRT, IGRT and volumetric modulated arc therapy, stereotactic body radiotherapy, stereotactic radiotherapy, stereotactic radiosurgery and brachytherapy. In August 2014, the Company acquired certain assets of Transpire, Inc., including Acuros dose calculation software that has been integrated into Varian's BrachyVision and Eclipse treatment planning software products.

Officers and directors

R. Andrew Eckert Independent Chairman of the Board
Age: 52
Bio & Compensation  - Reuters
Dow R. Wilson President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Elisha W. Finney Chief Financial Officer, Corporate Executive Vice President - Finance
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Clarence R. Verhoef Senior Vice President - Finance, Corporate Controller
Age: 58
Bio & Compensation  - Reuters
John W. Kuo Senior Vice President, General Counsel, Corporate Secretary
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kolleen T. Kennedy Senior Vice President, President - Oncology Systems
Age: 54
Bio & Compensation  - Reuters
Sunny Sanyal Senior Vice President; President, Imaging Components Businesses
Age: 49
Bio & Compensation  - Reuters
Timothy E. Guertin Non-Executive Vice Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Susan L. Bostrom Independent Director
Age: 53
Bio & Compensation  - Reuters
Regina E. Dugan Ph.D. Independent Director
Age: 51
Bio & Compensation  - Reuters